Defilade Capital Management’s Medtronic MDT Stock Holding History

Defilade Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.7M	Buy	+303,301	New	+$24.5M	3.18%	14

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Defilade Capital Management's MDT Position: Q2 2026 in Review

Defilade Capital Management opened a new position in Medtronic (MDT) in Q2 2026: 303,301 shares worth $23.7M. The stake represents 3.18% of the portfolio and ranks #14 among its holdings.

2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Defilade Capital Management held 303,301 shares of Medtronic worth $23.7M as of Q2 2026.
Medtronic was a new Defilade Capital Management position in Q2 2026.
Medtronic made up 3.18% of Defilade Capital Management's portfolio in Q2 2026, its #14 holding.
2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Defilade Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.